Ligand validation:5A3B

GLY: GLYCINE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5A3B_GLY_A_1297	39%	33%	0.143	0.848	1.14	1.52	1	-	0	0	100%	1
5A3B_GLY_A_1296	13%	26%	0.218	0.761	1.22	1.74	1	2	0	0	100%	1
5A3A_GLY_A_1298	57%	30%	0.154	0.928	1.15	1.63	1	-	0	0	100%	1
5A3C_GLY_A_1299	44%	27%	0.168	0.896	1.08	1.83	1	2	0	0	100%	1
5WET_GLY_A_301	100%	79%	0.017	0.997	0.59	0.29	-	-	0	0	80%	0.4
4YKJ_GLY_A_302	99%	34%	0.06	0.995	1.1	1.49	1	-	1	0	100%	0.24
1VD5_GLY_A_401	99%	19%	0.055	0.989	1.83	1.65	2	1	0	0	100%	1
5I57_GLY_A_1001	98%	34%	0.058	0.984	0.83	1.75	-	2	1	0	100%	1
3KGR_GLY_B_801	98%	27%	0.063	0.986	1.29	1.65	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.